Verily valuation, funding and investors
Verily works in precision health AI platform development, based in Dallas, United States. Founded in 2015, it has about 1,110 employees.
Tech Companies Growth Equity
VALUATION · TODAY
$3.25B −18% after Growth
Range $2.13B – $4.96B · Grade BTODAY
+12 MO
$5.00B
$10.00B
$15.00B
$20.00B
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Growth $1.00B
Growth $700M
Growth $1.00B
Growth $300M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,106 employees
−12%6m growth
−18%1y growth
−26%2y growth
1,000
2,000
Data from Jan 2021
Predicted in 1 yr $2.66B −18% vs today
Predicted next raise $321M if a round comes
Winding-down probability 95%
- Last round
- Growth · $300M · Mar 2026
- Valuation at last round
- $3.33B · implied
- Headcount
- 1,106 · down
- Grade
- B
- Founded
- 2015
Verily valuation today
VCMC values Verily at $3.3B today, with a range of $2.1B to $5.0B and a grade of B. The valuation starts from its last funding round, a growth round in Mar 2026.
Valuation by date (147 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $5.17M | $1.88M – $14.2M | $5.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.19M | $1.89M – $14.2M | $5.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.21M | $1.90M – $14.3M | $5.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.23M | $1.90M – $14.4M | $5.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.25M | $1.91M – $14.4M | $5.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.27M | $1.92M – $14.5M | $5.52M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.29M | $1.93M – $14.5M | $5.54M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.31M | $1.93M – $14.6M | $5.69M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.33M | $1.94M – $14.6M | $5.84M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $5.35M | $1.95M – $14.7M | $5.99M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $5.37M | $1.96M – $14.8M | $6.16M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $5.39M | $1.96M – $14.8M | $6.32M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $5.41M | $1.97M – $14.9M | $6.49M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.44M | $1.98M – $14.9M | $6.67M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.46M | $1.99M – $15.0M | $6.84M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.48M | $1.99M – $15.0M | $7.02M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.50M | $2.00M – $15.1M | $7.21M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.52M | $2.01M – $15.2M | $7.40M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $5.54M | $2.02M – $15.2M | $7.60M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $5.69M | $2.07M – $15.6M | $7.80M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $5.84M | $2.13M – $16.1M | $8.01M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $6.00M | $2.18M – $16.5M | $8.22M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.16M | $2.24M – $16.9M | $8.45M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.32M | $2.30M – $17.4M | $8.67M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $6.49M | $2.36M – $17.8M | $8.90M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $6.67M | $2.43M – $18.3M | $9.14M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $6.83M | $2.49M – $18.8M | $9.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $7.01M | $2.55M – $19.3M | $9.62M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $7.20M | $2.62M – $19.8M | $9.87M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $7.39M | $2.69M – $20.3M | $10.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $7.59M | $2.76M – $20.8M | $10.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $7.79M | $2.84M – $21.4M | $10.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $8.01M | $2.91M – $22.0M | $11.0M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $8.22M | $2.99M – $22.6M | $11.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $8.44M | $3.07M – $23.2M | $11.6M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $8.66M | $3.15M – $23.8M | $11.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $8.90M | $3.24M – $24.4M | $12.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $9.14M | $3.33M – $25.1M | $12.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $9.36M | $3.41M – $25.7M | $12.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $9.62M | $3.50M – $26.4M | $13.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $9.87M | $3.59M – $27.1M | $13.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $10.1M | $3.69M – $27.8M | $13.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $10.4M | $3.79M – $28.6M | $14.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $10.7M | $3.89M – $29.4M | $14.4M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $11.0M | $4.00M – $30.2M | $14.5M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $11.3M | $4.10M – $30.9M | $14.7M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $11.6M | $4.21M – $31.8M | $14.8M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $11.9M | $4.32M – $32.6M | $14.9M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $12.2M | $4.44M – $33.5M | $15.1M (+24%) | before first round | – | unknown | D | 0% |
| 4 Jan 2019 | $11.1B | $7.3B – $18.6B | $12.2B (+10%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $11.2B | $7.3B – $18.6B | $12.2B (+9%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $11.3B | $7.3B – $18.6B | $12.2B (+8%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $11.4B | $7.3B – $18.6B | $12.2B (+8%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $11.5B | $7.3B – $18.6B | $12.2B (+7%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $11.6B | $7.3B – $18.6B | $12.2B (+6%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $11.6B | $7.3B – $18.6B | $12.2B (+5%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $11.7B | $7.3B – $18.6B | $12.2B (+4%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $11.8B | $7.3B – $18.6B | $12.2B (+3%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $11.9B | $7.3B – $18.6B | $12.2B (+2%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $12.0B | $7.3B – $18.6B | $12.2B (+2%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $12.1B | $7.3B – $18.6B | $12.2B (+1%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $12.2B | $7.3B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Feb 2020 | $12.2B | $7.0B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Mar 2020 | $12.2B | $6.6B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Apr 2020 | $12.2B | $6.3B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $12.2B | $6.0B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $12.2B | $5.7B – $18.6B | $12.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $12.2B | $5.4B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $12.2B | $5.2B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $12.2B | $4.9B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $12.2B | $4.7B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $12.2B | $4.4B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $12.2B | $4.2B – $18.6B | $12.2B (0%) | after a round | – | unknown | C | 0% |
| 18 Dec 2020 | $7.8B | $5.1B – $13.0B | $8.6B (+10%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $7.8B | $5.1B – $13.0B | $8.6B (+10%) | after a round | 800 | unknown | B | 0% |
| 1 Feb 2021 | $7.9B | $5.1B – $13.0B | $8.6B (+9%) | after a round | 800 | unknown | B | 0% |
| 1 Mar 2021 | $7.9B | $5.1B – $13.0B | $8.6B (+8%) | after a round | 800 | unknown | B | 0% |
| 1 Apr 2021 | $8.0B | $5.1B – $13.0B | $8.6B (+7%) | after a round | 800 | unknown | B | 0% |
| 1 May 2021 | $8.1B | $5.1B – $13.0B | $8.6B (+6%) | after a round | 800 | unknown | B | 0% |
| 1 Jun 2021 | $8.1B | $5.1B – $13.0B | $8.6B (+5%) | after a round | 800 | unknown | B | 0% |
| 1 Jul 2021 | $8.2B | $5.1B – $13.0B | $8.6B (+5%) | after a round | 800 | unknown | B | 0% |
| 1 Aug 2021 | $8.3B | $5.1B – $13.0B | $8.6B (+4%) | after a round | 800 | unknown | B | 0% |
| 1 Sep 2021 | $8.3B | $5.1B – $13.0B | $8.6B (+3%) | after a round | 800 | unknown | B | 0% |
| 1 Oct 2021 | $8.4B | $5.1B – $13.0B | $8.6B (+2%) | after a round | 800 | unknown | B | 0% |
| 1 Nov 2021 | $8.5B | $5.1B – $13.0B | $8.6B (+1%) | after a round | 800 | unknown | B | 0% |
| 1 Dec 2021 | $8.5B | $5.1B – $13.0B | $8.6B (0%) | after a round | 800 | unknown | B | 0% |
| 1 Jan 2022 | $8.6B | $5.0B – $13.0B | $8.6B (0%) | after a round | 800 | unknown | B | 0% |
| 1 Feb 2022 | $8.6B | $4.7B – $13.0B | $8.6B (0%) | after a round | 800 | unknown | B | 0% |
| 1 Mar 2022 | $8.6B | $4.5B – $13.0B | $8.6B (0%) | after a round | 800 | unknown | B | 0% |
| 1 Apr 2022 | $8.6B | $4.3B – $13.0B | $8.6B (0%) | after a round | 800 | unknown | B | 0% |
| 1 May 2022 | $9.5B | $5.5B – $14.5B | $9.5B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Jun 2022 | $9.5B | $5.5B – $14.5B | $9.5B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Jul 2022 | $9.5B | $5.4B – $14.5B | $9.5B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Aug 2022 | $9.5B | $3.9B – $14.5B | $9.5B (0%) | after a round | 1,300 | unknown | C | 0% |
| 1 Sep 2022 | $9.5B | $3.7B – $14.5B | $9.5B (0%) | after a round | 1,300 | unknown | C | 0% |
| 10 Sep 2022 | $10.8B | $7.6B – $16.8B | $11.8B (+10%) | after a round | 1,300 | unknown | B | 0% |
| 1 Oct 2022 | $10.8B | $7.6B – $16.8B | $11.8B (+9%) | after a round | 1,300 | unknown | B | 0% |
| 1 Nov 2022 | $10.9B | $7.6B – $16.8B | $11.8B (+8%) | after a round | 1,300 | unknown | B | 0% |
| 1 Dec 2022 | $11.0B | $7.6B – $16.8B | $11.8B (+8%) | after a round | 1,300 | unknown | B | 0% |
| 1 Jan 2023 | $11.1B | $7.6B – $16.8B | $11.8B (+7%) | after a round | 1,300 | unknown | B | 0% |
| 1 Feb 2023 | $11.2B | $7.6B – $16.8B | $11.8B (+6%) | after a round | 1,600 | up | B | 0% |
| 1 Mar 2023 | $11.2B | $7.6B – $16.8B | $11.8B (+5%) | after a round | 1,600 | up | B | 0% |
| 1 Apr 2023 | $11.3B | $7.6B – $16.8B | $11.8B (+4%) | after a round | 1,600 | up | B | 0% |
| 1 May 2023 | $11.4B | $7.6B – $16.8B | $11.8B (+3%) | after a round | 1,600 | up | B | 0% |
| 1 Jun 2023 | $11.5B | $7.6B – $16.8B | $11.8B (+3%) | after a round | 1,600 | up | B | 0% |
| 1 Jul 2023 | $11.6B | $7.6B – $16.8B | $11.8B (+2%) | after a round | 1,600 | up | B | 0% |
| 1 Aug 2023 | $11.7B | $7.6B – $16.8B | $11.8B (+1%) | after a round | 1,600 | up | B | 0% |
| 1 Sep 2023 | $11.8B | $7.6B – $16.8B | $11.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Oct 2023 | $11.8B | $7.4B – $16.8B | $11.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Nov 2023 | $11.8B | $6.9B – $16.8B | $11.8B (0%) | after a round | 1,600 | flat | B | 0% |
| 1 Dec 2023 | $11.8B | $6.6B – $16.8B | $11.8B (0%) | after a round | 1,600 | flat | B | 0% |
| 1 Jan 2024 | $11.8B | $6.3B – $16.8B | $11.8B (0%) | after a round | 1,600 | flat | B | 0% |
| 1 Feb 2024 | $11.8B | $6.0B – $16.8B | $11.8B (0%) | after a round | 1,600 | flat | B | 0% |
| 1 Mar 2024 | $10.8B | $5.6B – $16.2B | $9.7B (-11%) | after a round | 1,500 | flat | B | 27% |
| 1 Apr 2024 | $10.6B | $5.3B – $16.2B | $9.2B (-13%) | after a round | 1,500 | flat | B | 34% |
| 1 May 2024 | $10.5B | $5.1B – $16.2B | $9.1B (-13%) | after a round | 1,500 | flat | B | 34% |
| 1 Jun 2024 | $10.3B | $4.8B – $16.2B | $9.0B (-13%) | after a round | 1,500 | flat | C | 34% |
| 1 Jul 2024 | $10.2B | $4.6B – $16.2B | $8.9B (-13%) | after a round | 1,500 | flat | C | 34% |
| 1 Aug 2024 | $10.2B | $4.4B – $16.3B | $8.9B (-13%) | after a round | 1,500 | flat | C | 32% |
| 1 Sep 2024 | $10.2B | $4.2B – $16.3B | $9.0B (-12%) | after a round | 1,500 | flat | C | 30% |
| 1 Oct 2024 | $10.1B | $4.0B – $16.3B | $8.7B (-14%) | after a round | 1,500 | flat | C | 28% |
| 1 Nov 2024 | $10.0B | $3.8B – $16.4B | $8.6B (-14%) | after a round | 1,500 | flat | C | 28% |
| 1 Dec 2024 | $10.0B | $3.6B – $16.4B | $8.6B (-14%) | after a round | 1,500 | flat | C | 27% |
| 1 Jan 2025 | $9.9B | $3.4B – $16.4B | $8.4B (-15%) | after a round | 1,500 | flat | C | 27% |
| 1 Feb 2025 | $9.8B | $3.2B – $16.4B | $8.3B (-15%) | after a round | 1,500 | flat | C | 27% |
| 1 Mar 2025 | $9.7B | $3.1B – $16.4B | $8.2B (-16%) | after a round | 1,500 | flat | C | 27% |
| 1 Apr 2025 | $9.7B | $2.9B – $16.5B | $8.1B (-17%) | after a round | 1,500 | flat | C | 27% |
| 1 May 2025 | $9.7B | $2.8B – $16.5B | $8.1B (-16%) | after a round | 1,500 | flat | C | 25% |
| 1 Jun 2025 | $9.8B | $2.7B – $16.5B | $8.2B (-16%) | after a round | 1,500 | flat | C | 23% |
| 1 Jul 2025 | $9.9B | $2.5B – $16.5B | $8.3B (-16%) | after a round | 1,500 | flat | C | 21% |
| 1 Aug 2025 | $7.3B | $2.3B – $16.1B | $5.3B (-28%) | after a round | 1,345 | down | C | 53% |
| 1 Sep 2025 | $6.4B | $2.2B – $16.1B | $4.3B (-33%) | after a round | 1,342 | down | C | 66% |
| 1 Oct 2025 | $6.1B | $2.1B – $14.3B | $4.6B (-24%) | after a round | 1,342 | down | C | 62% |
| 1 Nov 2025 | $5.9B | $2.0B – $14.2B | $4.5B (-24%) | after a round | 1,342 | down | C | 62% |
| 1 Dec 2025 | $4.7B | $1.9B – $13.5B | $3.4B (-28%) | after a round | 1,277 | down | C | 80% |
| 1 Jan 2026 | $4.6B | $1.8B – $13.3B | $3.3B (-28%) | after a round | 1,277 | down | D | 80% |
| 1 Feb 2026 | $4.3B | $1.7B – $13.2B | $3.1B (-28%) | after a round | 1,277 | down | D | 81% |
| 1 Mar 2026 | $4.4B | $1.6B – $13.2B | $3.2B (-27%) | after a round | 1,277 | down | D | 77% |
| 20 Mar 2026 | $3.3B | $2.2B – $5.1B | $3.4B (+1%) | after a round | 1,255 | down | B | 93% |
| 1 Apr 2026 | $3.3B | $2.2B – $5.1B | $3.3B (-1%) | after a round | 1,255 | down | B | 93% |
| 1 May 2026 | $3.3B | $2.2B – $5.1B | $3.2B (-3%) | after a round | 1,255 | down | B | 93% |
| 1 Jun 2026 | $3.3B | $2.2B – $5.1B | $3.2B (-5%) | after a round | 1,255 | flat | B | 86% |
| 1 Jul 2026 | $3.4B | $2.2B – $5.2B | $3.1B (-6%) | after a round | 1,255 | flat | B | 79% |
| 1 Aug 2026 | $3.4B | $2.2B – $5.2B | $3.1B (-8%) | after a round | 1,255 | flat | B | 73% |
| 1 Sep 2026 | $3.4B | $2.2B – $5.2B | $3.1B (-9%) | after a round | 1,255 | flat | B | 67% |
| 1 Oct 2026 | $3.3B | $2.1B – $5.0B | $2.7B (-17%) | after a round | 1,106 | down | B | 95% |
| 24 Oct 2026 | $3.3B | $2.1B – $5.0B | $2.7B (-18%) | after a round | 1,106 | down | B | 95% |
Key facts about Verily
- Founded
- 2015
- Headquarters
- Dallas, United States
- Employees
- about 1,110 -18% in a year
- Total raised
- $3.00B
- Funding rounds
- 4
- Last round
- Growth Equity Mar 2026
Verily was founded in 2015 by Andy Conrad and Thomas Insel.
Verily funding history
Verily has 4 funding rounds on record, from Jan 2019 to Mar 2026, $3.00B in total. None disclosed a valuation.
Growth Equity 19 Mar 2026
Led by Series X Capital; with Alphabet, UCHealth, University of Colorado Anschutz.
Sources: verily.com, mobihealthnews.com, beckershospitalreview.com and 3 more
$300M
Growth Equity 9 Sep 2022
Led by Alphabet.
Sources: verily.com, statnews.com, techcrunch.com and 3 more
$1.00B
Growth Equity 17 Dec 2020
With Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan.
Sources: verily.com, cnbc.com, mobihealthnews.com
$700M
Growth Equity 3 Jan 2019
Led by Silver Lake; with Ontario Teachers’ Pension Plan, Alphabet.
Sources: tadviser.com, verily.com, en.wikipedia.org
$1.00B
Verily investors
7 investors have backed Verily; Alphabet, Silver Lake and Series X Capital led at least one round.
- Alphabet lead, 4 rounds
- Silver Lake lead, 2 rounds
- Series X Capital lead
- Ontario Teachers’ Pension Plan 2 rounds
- Temasek
- UCHealth
- University of Colorado Anschutz
What Verily does
Verily works in tech companies, with 15 recorded offerings and customers in healthcare and health technology.
Verily Life Sciences LLC is an American company that operates in the healthcare technology and life sciences sectors. The company develops and provides AI-native platforms and solutions for precision health, including consumer health apps, clinical research tools, and population health monitoring systems. Verily serves healthcare providers, employers, and consumers, and is involved in research and development within the biotechnology and health care industries.
Description from Veridion's company data.
Products and services
- Precision Health AI Platform Development
- Personalized Health Recommendation Services
- Clinical Research Acceleration Solutions
- Population Health Monitoring Solutions
- Healthcare Data Transformation Services
- AI-Powered Patient Outcome Improvement Services
- Healthcare Delivery Enhancement Solutions
- Healthcare Technology Research and Development
- Healthcare Industry Partnership Development
- Consumer Health App Services
- Healthcare Provider Solutions Distribution
- Employer Health Program Solutions
- Public Health Data Analysis Solutions
- Clinical Data Integration Services
- Healthcare Analytics Solutions Development
Markets
- Healthcare
- Health Technology
Technology
- AI-Native Platforms for Precision Health
- AI-Powered Precision Health
- AI-Driven Personalized Health Recommendations
- AI-Enabled Clinical Research Acceleration
- AI-Mediated Population Disease Monitoring
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Software-as-a-Service
Industry codes (NAICS)
- 513210 Software Publishers 70% match
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) 30% match
Questions about Verily
What is Verily worth?
Valuation $3.3B (range $2.1B to $5.0B), as of 24 Oct 2026.
Has Verily raised money?
Verily has 4 funding rounds on record, from Jan 2019 to Mar 2026, $3.00B in total. None disclosed a valuation.
Who has invested in Verily?
Alphabet, Silver Lake, Series X Capital, Ontario Teachers’ Pension Plan, Temasek and UCHealth, and 1 more. Lead investors include Alphabet, Silver Lake and Series X Capital.
How many people work at Verily?
About 1,110, down 18% over the last year. Headcount rose from 800 in Jan 2021 to 1,600 in Jan 2023, then fell to 1,106 in Sep 2026.
What does Verily do?
Verily works in tech companies, with 15 recorded offerings and customers in healthcare and health technology. Its main offerings are precision health AI platform development, personalized health recommendation services and clinical research acceleration solutions.
When was Verily founded, and where is it based?
Verily was founded in 2015 and is based in Dallas, United States. It has about 1,110 employees, down 18% over the last year.